This trial screens patients with colon or rectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable) for genetic mutations for recommendation

NIAID Data Ecosystem70

Data from: Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR

癌症基因检测

下一代测序技术

Objective: To validate the targeted next-generation sequencing (NGS) platform-Ion Torrent PGM for KRAS exon 2 and expanded RAS mutations detection in formalin-fixed paraffin-embedded (FFPE) colorectal

DataONE2015-12-11 更新30

Additional file 5: of Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naĂŻve lung adenocarcinoma

癌症基因检测

靶向测序

Table S4. Reproducibility of targeted deep sequencing without MBS. (XLSX 12 kb)

DataCite Commons2024-02-26 更新70

CancerNextExpanded+RNAinsight multi-gene panel from Ambry Genetics Laboratories

癌症基因检测

遗传分析

This supplemental material contains the 77 genes tested in the Ambry Genetics multi-gene panel.

NIAID Data Ecosystem50